MedPath

To study of effect of sarsaparilla officinalis and constitutional homoeopathic medicine in reducing the size of stone and symptoms of kidney stone

Phase 3
Conditions
Health Condition 1: N20-N23- Urolithiasis
Registration Number
CTRI/2024/02/062621
Lead Sponsor
Dr C Shahanas
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Cases of urolithiasis diagnosed by ultrasonogram (KUB)

Age group from 20 - 60 years of both sexes

Size of the stone up to 12mm

Exclusion Criteria

Cases with impacted stone or with stag horn calculi

Patients with severe illnesses or end-stage diseases like malignancies.

Gross developmental or structural abnormalities of the urinary system

Cases with moderate or severe hydronephrosis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Each case will be reviewed at 2 to 3 weeks interval <br/ ><br>changes in intensity of pain will be evaluated by changes in VAS score after homoeopathic medicine <br/ ><br>Reduction in size of kidney stone will be assessed using abdominal ultrasonography before and after homoeopathic medicine sarsaparilla and individualized homoeopathic medicine <br/ ><br>Timepoint: 6 months <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
There will be a comparison among the group to assess the effectiveness of Homoeopathic medicine sarsaparilla officinalis and individualized homoeopathic medicineTimepoint: 1 year
© Copyright 2025. All Rights Reserved by MedPath